| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.2B | $20.5B | $19.1B | $17.7B | $16.2B | $3.8B | $4.0B | $1.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $6.9B | $6.6B | $6.6B | $6.1B | $5.8B | $1.5B | $1.5B | $0.3B |
| Operating Income | $5.8B | $5.9B | $5.0B | $3.7B | $2.3B | $0.5B | $0.5B | $0.4B |
| Net Income | $3.5B | $3.1B | $3.1B | $2.5B | $1.3B | $0.3B | $0.2B | $0.3B |
| EPS (Basic) | $6.36 | $5.41 | $5.02 | $3.94 | $2.01 | $1.42 | $1.74 | $2.93 |
| EPS (Diluted) | $6.34 | $5.38 | $4.98 | $3.91 | $1.99 | $1.40 | $1.71 | $2.87 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $80.1B | $77.2B | $90.9B | $83.9B | $76.2B | $74.6B | $77.5B | $11.3B |
| Current Assets | $24.7B | $23.5B | $34.8B | $27.5B | $18.9B | $16.2B | $17.0B | $2.2B |
| Cash & Equivalents | $0.8B | $1.2B | $1.2B | $0.9B | $0.8B | — | — | — |
| Total Liabilities | $54.3B | $49.5B | $60.2B | $52.2B | $44.3B | $41.3B | $42.7B | $9.0B |
| Current Liabilities | $23.9B | $22.2B | $33.6B | $26.5B | $18.3B | $15.6B | $15.7B | $2.0B |
| Stockholders' Equity | $25.8B | $27.1B | $29.9B | $30.8B | $31.0B | $32.3B | $33.0B | $2.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.1B | $6.6B | $5.2B | $4.6B | $4.0B | $4.1B | — | — |
| Investing Cash Flow | $-2.5B | $-2.4B | $-1.1B | $-2.1B | $-1.6B | $-0.3B | — | — |
| Capital Expenditures | $1.8B | $1.6B | $1.4B | $1.5B | $1.2B | $0.9B | $0.7B | $0.4B |
| Financing Cash Flow | $-3.8B | $-4.2B | $-4.4B | $-2.5B | $-1.7B | $-3.8B | — | — |